DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹926 Cr | ₹633 Cr | ₹-37 Cr | ₹-278 Cr | ₹-508 Cr |
What is the latest Total Non-Current Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹926 Cr |
| Mar2025 | ₹633 Cr |
| Mar2024 | ₹-37 Cr |
| Mar2023 | ₹-278 Cr |
| Mar2022 | ₹-508 Cr |
How is Total Non-Current Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹926 Cr | 46.33 | |
| Mar2025 | ₹633 Cr | Positive | |
| Mar2024 | ₹-37 Cr | Negative | |
| Mar2023 | ₹-278 Cr | Negative | |
| Mar2022 | ₹-508 Cr | - | |
Compare Total Non-Current Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹97,751.7 Cr | 2.7% | -0.7% | -12.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | 0.1% | -0.6% | 15.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | -0.6% | 8.7% | 53% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -0.8% | -1.7% | 34.7% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | -0.6% | -4.2% | -12.9% | Stock Analytics | |
| MANKIND PHARMA | ₹95,743.9 Cr | 2.2% | -4% | -13.4% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 2.7% |
-0.7% |
-12.1% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses